Materials · Specialty Chemicals

Avient Corporation AVNT

$36.68+0.76 (+2.12%)delayed quote · as of 2026-07-30 20:42 UTC

Open AVNT in the workspaceCharts, statements, and the evidence behind every figure — free to start.

Market cap

$3.4B

Previous close

$35.92

Volume

493K

52-week range

$27.48 – $44.85

Verdictconfidence 100% · high

Health stands out; quality flashes caution.

4 of 5 dimensions score well; quality flashes caution.

Value502/4 checks

Growth502/4 checks

Quality331/3 checks

Health1003/3 checks

Momentum603/5 checks

Fair-value estimate $2.03 per share (2-stage FCF · individual beta · 10Y Rf 4.7%) — the price sits 1707% above it.

Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.

Key ratioslatest filing FY 2025

Value

P/E TTM

21.3

P/E FWD

10.8

EV/EBITDA TTM

9.8

PEG

0.53

Growth

Revenue 3y

−1.4%/yr

Revenue YoY

+0.6%

Expected EPS

+96.7%

Quality

ROE

3.4%

Quality checks

bank measures

Health

Equity/assets

39.4%

Solvency score

n/a for financials

Momentum

vs 50-day

−2.8%

vs 200-day

+7.1%

52-wk range

53%

FY 2025: revenue $3.3B · net income $81.9M · free cash flow $195.0M (SEC EDGAR filings)

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-30 20:42 UTC · fundamentals FY 2025 · SEC EDGAR

Verdict

Reading AVNT’s filed statements…

Continue with AVNT in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.